期刊
SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41598-017-05907-8
关键词
-
资金
- NIH [R01 CA141057]
- German Research Foundation stipend [STA1458/1-1]
Advanced colorectal cancer (CRC) remains a critical health care challenge worldwide. Various TGF-beta superfamily members are important in colorectal cancer metastasis, but their signaling effects and predictive value have only been assessed in isolation. Here, we examine cross-regulation and combined functions of the two most prominent TGF-beta superfamily members activin and TGF-beta in advanced colorectal cancer. In two clinical cohorts we observed by immune-based assay that combined serum and tissue activin and TGF-beta ligand levels predicts outcome in CRC patients and is superior to single ligand assessment. While TGF-beta growth suppression is independent of activin, TGF-beta treatment leads to increased activin secretion in colon cancer cells and TGF-beta induced cellular migration is dependent on activin, indicating pathway cross-regulation and functional interaction in vitro. mRNA expression of activin and TGF-beta pathway members were queried in silico using the TCGA data set. Coordinated ligand and receptor expression is common in solid tumors for activin and TGF-beta pathway members. In conclusion, activin and TGF-beta are strongly connected signaling pathways that are important in advanced CRC. Assessing activin and TGF-beta signaling as a unit yields important insights applicable to future diagnostic and therapeutic interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据